10
Dec
Adobe (ADBE): AI Booster With Saturation Drag
The creative moat holds. But growth’s grinding slower.
5 min read
Analysis
In-depth, data-driven breakdowns of companies, sectors, and market trends.
03
Dec
Apple (AAPL): Fortress on Fumes
$100B in free cash flow. 8% growth. 36× earnings. The math doesn't math.
4 min read
26
Nov
CAT's Trading Like It's Nvidia. It's Not. Here's the Math.
At $520, you're not buying strength — you're buying hope.
8 min read
19
Nov
AbbVie: Boring Business, Beautiful Cash Flow
AbbVie survived the Humira patent cliff everyone feared. Now at single-digit P/E with $22B in free cash flow and a 3% yield, you're paying for pharma discipline while others chase biotech moonshots. Sometimes boring wins.
3 min read
12
Nov
Chevron: Built for Cash, Not Clicks
Chevron survived the Hess deal distraction. Now at $153 with 80% upstream margins and FCF covering dividends 1.7x, you're paying for discipline at 16.5× earnings. Guyana's $35 breakevens change everything. Target: $170 by 2027.
3 min read
05
Nov
Palantir: The Cult Stock That Forgot It’s Not a Religion
The fundamentals scream brilliance. The price screams mania.
4 min read
09
Oct
$NVDA: Hold — AI Powerhouse, But Perfection Is Already Priced In
NVIDIA’s still the AI powerhouse — but perfection is already priced in. Record revenue and elite margins can’t defy gravity forever. Here’s why I’m holding, not chasing.
3 min read
07
Oct
Tesla, Inc. (NASDAQ: TSLA): Priced for Perfection, Delivering Automaker Economics
Tesla is still the world’s most exciting car company. But at $440 a share, investors aren’t buying cars—they’re buying science fiction.
8 min read
04
Oct
$JNJ: Dividend King or Lawsuit Trap?
JNJ isn’t broken.
But at $188, you’re paying growth multiples for a dividend stock with unlimited liability.
That’s not prudent — that’s hopeful.
2 min read
27
Sep
The Costco Thesis
Bottom line: the fees pay for low prices, and low prices keep members hooked. My $1,200-$1,300 target for Costco by 2028.
4 min read